Loading...
XJPX8129
Market cap1.77bUSD
Dec 27, Last price  
4,260.00JPY
1D
1.55%
1Q
-8.39%
Jan 2017
82.68%
Name

Toho Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:8129 chart
P/E
13.49
P/S
0.19
EPS
315.76
Div Yield, %
0.80%
Shrs. gr., 5y
-1.57%
Rev. gr., 5y
3.86%
Revenues
1.48t
+6.35%
603,586,000,000706,488,000,000773,441,000,000805,414,000,000838,949,000,0001,002,112,000,0001,059,581,000,0001,108,144,000,0001,140,357,000,0001,189,624,000,0001,162,114,000,0001,308,358,000,0001,231,175,000,0001,213,322,000,0001,222,195,000,0001,263,769,000,0001,210,334,000,0001,266,171,000,0001,388,565,000,0001,476,712,000,000
Net income
20.66b
+51.56%
3,405,000,0003,612,000,0007,218,000,0008,381,000,000-2,471,000,0008,263,000,0007,283,000,00010,766,000,00011,526,000,00010,407,000,00013,535,000,00021,771,000,00014,225,000,00014,384,000,00013,863,000,00016,230,000,0004,989,000,00013,379,000,00013,630,000,00020,657,000,000
CFO
59.93b
P
7,172,000,0004,613,000,00024,273,000,000-12,996,000,0009,963,000,0001,998,000,0009,726,000,00019,366,000,00024,558,000,000-18,636,000,00029,347,000,0002,381,000,00016,062,000,00051,978,000,00013,428,000,00010,815,000,0008,768,000,00016,341,000,000-9,000,00059,934,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Feb 06, 2025

Profile

Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.
URL
https://www.tohohd.co.jp/
IPO date
Dec 11, 2002
Employees
7,699
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,476,712,000
6.35%
1,388,565,000
9.67%
1,266,171,000
4.61%
Cost of revenue
1,449,002,000
1,279,175,000
1,158,549,000
Unusual Expense (Income)
NOPBT
27,710,000
109,390,000
107,622,000
NOPBT Margin
1.88%
7.88%
8.50%
Operating Taxes
10,113,000
6,769,000
6,695,000
Tax Rate
36.50%
6.19%
6.22%
NOPAT
17,597,000
102,621,000
100,927,000
Net income
20,657,000
51.56%
13,630,000
1.88%
13,379,000
168.17%
Dividends
(2,235,000)
(2,187,000)
(2,116,000)
Dividend yield
0.85%
1.23%
1.49%
Proceeds from repurchase of equity
(12,002,000)
(4,267,000)
BB yield
4.56%
2.41%
Debt
Debt current
1,126,000
30,393,000
7,141,000
Long-term debt
30,644,000
9,108,000
35,169,000
Deferred revenue
6,000
10,104,000
8,803,000
Other long-term liabilities
11,103,000
1,396,000
887,000
Net debt
(171,925,000)
(128,374,000)
(136,652,000)
Cash flow
Cash from operating activities
59,934,000
(9,000)
16,341,000
CAPEX
(2,505,000)
(2,519,000)
(4,202,000)
Cash from investing activities
9,091,000
4,315,000
(11,032,000)
Cash from financing activities
(22,195,000)
(13,060,000)
(4,473,000)
FCF
55,744,000
92,654,000
101,678,000
Balance
Cash
132,970,000
86,201,000
94,256,000
Long term investments
70,725,000
81,674,000
84,706,000
Excess cash
129,859,400
98,446,750
115,653,450
Stockholders' equity
235,130,000
445,095,000
432,181,000
Invested Capital
160,921,600
188,704,250
170,635,550
ROIC
10.07%
57.12%
59.67%
ROCE
9.14%
36.42%
35.72%
EV
Common stock shares outstanding
72,028
75,369
76,604
Price
3,652.00
55.40%
2,350.00
27.03%
1,850.00
-8.87%
Market cap
263,047,399
48.52%
177,117,371
24.98%
141,716,662
-8.85%
EV
91,226,399
277,054,371
229,674,662
EBITDA
34,224,000
115,803,000
114,579,000
EV/EBITDA
2.67
2.39
2.00
Interest
145,000
72,000
76,000
Interest/NOPBT
0.52%
0.07%
0.07%